Investing News NetworkYour trusted source for investing success

Videos
Companies
Press Releases
Top Stocks
Top Resource Stocks
Top Tech Stocks
Top Life Science Stocks
Private Placements
Trending
Trending Articles

How Would a New BRICS Currency Affect the US Dollar? (Updated 2024)

13 Canadian Crypto ETFs (Updated 2024)

Rare Earths Stocks: 9 Biggest Companies in 2024

Could the Silver Price Really Hit $100 per Ounce? (Updated 2024)

10 Top Oil-producing Countries (Updated 2024)

A State-by-State Guide to Cannabis in Australia (Updated 2024)

Uranium Stocks: 5 Biggest Companies in 2024

When is the Starlink IPO Date and Can You Invest? (Updated 2024)

Top 5 Canadian Mining Stocks This Week: Sanu Gold Sparkles with 200 Percent Gain

Trending Press Releases

SAGA Metals Reports Channel Sample Assay Results at Double Mer Uranium Project

Radiopharm achieves Nasdaq listing of ADS

HyProMag USA Feasibility Study Demonstrates Robust Economics and the Opportunity to Develop a Major New, Domestic Source of Recycled Rare Earths Magnets for the United States

Extension of Option to Acquire Major Nickel Asset

Trillion Energy Successfully Re-completes Wells in VS Program

Lithium Universe Ltd Partners with Quebec Chemical Logistics Supply Company

More Press Releases
Trending Companies

Purpose Bitcoin ETF

BTCC:CA

Soma Gold Corp.

SOMA:CA

MP Materials Corp.

MP:US

First Helium

HELI:CA
More Companies
Trending Reports

2024 Gold Outlook Report

2024 Lithium Market Outlook

Silver Price Forecast - What Happened And Where Do We Go From Here?

2024 Uranium Outlook

More Outlook Reports
Resource
Resource
Popular Lists
Investing Ideas
Outlook Reports
Investing Guides
Tech
Tech
Popular Lists
Investing Ideas
Outlook Reports
Investing Guides
Life Science
Life Science
Popular Lists
Investing Ideas
Outlook Reports
Investing Guides
Gold Price
Silver Price
Copper Price
Oil Price
Uranium
Artificial Intelligence
loader

Aerovate Therapeutics Inc.

NASDAQ:AVTE
Press Releases

Aerovate Therapeutics Presents Baseline Data from the Phase 2b Portion of the IMPAHCT Trial at the American Thoracic Society 2024 International Conference

Aerovate Therapeutics Announces First Quarter Financial Results and Business Highlights

Aerovate Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing drugs that improve the lives of patients with rare cardiopulmonary disease. Its initial focus is on advancing AV-101, dry powder inhaled formulation of imatinib for the treatment of pulmonary arterial hypertension, a devastating disease impacting people in the United States and Europe.

Interactive Chart

×